An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapy
Open Access
- 23 July 2020
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 58, 102897
- https://doi.org/10.1016/j.ebiom.2020.102897
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of China (81761148025)
- National Natural Science Foundation of China (81871473, 81402158)
- Guangzhou Science and Technology Programme (201704020093)
- Fundamental Research Funds for the Central Universities (17ykzd15, 19ykyjs07)
- National Supercomputer Center
- National Research Foundation (17–54–80078)
- Russian Foundation for Basic Research
This publication has 57 references indexed in Scilit:
- Nanoparticle-based drug delivery to the vagina: A reviewJournal of Controlled Release, 2014
- Nanopharmaceuticals for improved topical vaginal therapy: Can they deliver?European Journal of Pharmaceutical Sciences, 2013
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsNature Biotechnology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensNature Biotechnology, 2012
- Liposomal Delivery System Enhances Anti-Inflammatory Properties of CurcuminJournal of Pharmaceutical Sciences, 2012
- An effective method for the quantitative detection of porcine endogenous retrovirus in pig tissuesIn Vitro Cellular & Developmental Biology – Animal, 2010
- A Combinatorial Polymer Library Approach Yields Insight into Nonviral Gene DeliveryAccounts of Chemical Research, 2008
- A Review of Current Intravaginal Drug Delivery Approaches Employed for the Prophylaxis of HIV/AIDS and Prevention of Sexually Transmitted InfectionsAAPS PharmSciTech, 2008
- Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicideInternational Journal of Pharmaceutics, 2006